Presentation is loading. Please wait.

Presentation is loading. Please wait.

Update from AB – Calgary Zone

Similar presentations


Presentation on theme: "Update from AB – Calgary Zone"— Presentation transcript:

1 Update from AB – Calgary Zone
M. Taher Rad, MD, FRCPC

2 Transfusion Medicine Clinical Section (CZ)
Starting July 2015, Transfusion Medicine has been established as independent clinical section within CLS and University of Calgary Dr Leland Baskin is the new clinical section chief for Transfusion Medicine M. Taher Rad will continue to represent CZ in NAC

3 IVIG Utilization Program – CZ (Outlines)
Establishment of an Calgary Zone medical advisory committee for IVIG Development of a comprehensive registry database for patients receiving IVIG (Entry, follow-up, monitoring and exit from program) BC’s IVIG utilization software will be used online data collection system Submission of Ethical approval for registry database and performing regional observational IVIG utilization projects Collection of data following eligibility, follow-up guideline by IVIG committee Screening of qualified patients for SCIG program following criteria established by IVIG committee Training of patients and issuance of certificate of training. Arrangement for dispensing the product at the closest hospital/Health care centre The time frame of project is 2 years and in case of successful outcomes, continuation of project shall be negotiated with provincial Health care stakeholders. The program has been funded by CSL-Behring and approved by AHS legal office.

4 IVIG Utilization Program - CZ
IVIG Medical Advisory Committee IVIG Utilization Database IVIG Utilization SCIG Program Utilization of Clinical Resources Categorization of Clinical Indications (EB) Patient Data Attending MD Registration/Entry Follow-up data IVIG Dosage Post IVIG hemolysis Inpatient IVIG Outpatient IVIG Dispensed product Data Referral by MD Training by CLS Pt certification Returning Pt to MD with a report summary Arrangement for dispensing the product at convenient place F/U on product delivered to the patients Non-Compliant Pt Day Med clinics TBCC Clinic Follow Up Criteria Objective Subjective Periodic Peer Review Eligibility Criteria for SCIG program Development of Forms Entry form (EB+) F/U form (EB+) Exit form Approval form (No EB) Entry form (No EB) F/U form (No EB) Peer Review Form EB; Evidence Based

5 CZ IVIG Medical Advisory Committee
Chair (Dr Andrew Daly – Chair) Clinical consultant ( Dr Tom Feasby) Scientific consultant (Dr Dana Devine, CBS) Program Co-ordinator External Consultants Neurology Adult Hematology & Immune deficiency Pediatric Hematology & Immune deficiency Rheumatology Infectious disease/AIDS Respiratory Dermatology AH (Alberta Health Ministry) representative Transfusion Medicine CSC Transfusion Medicine Operation AHS Lab utilization office/CLS clinical informatics (Dr Chris Naugler) Clinical Research Associate


Download ppt "Update from AB – Calgary Zone"

Similar presentations


Ads by Google